Not recruitingISRCTN15607817
A trial of the synthetic cannabinoid ART27.13 to stimulate appetite in patients with cancer anorexia and weight loss
Research studyAges 18–120United Kingdom + IrelandEating disorders
Understand this study
Who could participate?
Listed age limits: 18 years to 120 years.
- Listed locations
- United Kingdom · Ireland
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Artelo Biosciences Ltd.
- Sponsor type
- Biotech company
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- United Kingdom, Ireland
- Age range
- From 18 Years to 120 Years
- Official registry ID
- ISRCTN15607817
- Official title
Show the full official title
A trial of the synthetic cannabinoid ART27.13 to stimulate appetite in patients with cancer anorexia and weight loss
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
United Kingdom · Ireland
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Artelo Biosciences Ltd.
Who can participate?
Listed age limits: 18 years to 120 years.
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to explore more studies?
Explore studiesRelated studies
A comparison of two psychological treatments for severe Eating disorders
A Maudsley outpatient study of treatments for Eating disorders and related conditions
